How to buy Panbela Therapeutics stock (PBLA)

Panbela Therapeutics is a biotechnology business based in the US. Panbela Therapeutics shares (PBLA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.35 – a decrease of 4.82% over the previous week. Panbela Therapeutics employs 7 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Panbela Therapeutics stock

Buy Panbela Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Panbela Therapeutics stock price (NASDAQ: PBLA)

Use our graph to track the performance of PBLA stocks over time.

Panbela Therapeutics shares at a glance

• Key figures

Information last updated 2024-11-01.

Latest market close	$0.35
52-week range	$0.30 - $38.00
50-day moving average more info button	$0.37
200-day moving average more info button	$0.69
Wall St. target price	$500.00
PE ratio more info button	0.003
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$121.67

Is it a good time to buy Panbela Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Panbela Therapeutics price performance over time

Historical closes compared with the close of $0.357 from 2024-11-05

1 week (2024-10-30)	-6.05%
1 month (2024-10-03)	N/A
3 months (2024-08-03)	N/A
6 months (2024-05-03)	N/A

1 year (2023-11-03)	N/A
2 years (2022-11-03)	N/A
3 years (2021-11-03)	N/A
5 years (2019-11-03)	N/A

Is Panbela Therapeutics stock undervalued or overvalued?

Valuing Panbela Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Panbela Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Panbela Therapeutics's P/E ratio

Panbela Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Panbela Therapeutics shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Panbela Therapeutics financials

Gross profit TTM	$0
Return on assets TTM	-128.31%
Return on equity TTM	-798.16%
Profit margin	0%
Book value	$-2.18
Market Capitalization more info button	$1.8 million

TTM: trailing 12 months

Panbela Therapeutics share dividends

We're not expecting Panbela Therapeutics to pay a dividend over the next 12 months.

Have Panbela Therapeutics's shares ever split?

Panbela Therapeutics's shares were split on a 1:20 basis on 17 January 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Panbela Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Panbela Therapeutics shares which in turn could have impacted Panbela Therapeutics's share price.

Panbela Therapeutics share price volatility

Over the last 12 months, Panbela Therapeutics's shares have ranged in value from as little as $0.3 up to $38. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Panbela Therapeutics's is 0.982. This would suggest that Panbela Therapeutics's shares are less volatile than average (for this exchange).

Panbela Therapeutics overview

Panbela Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company's lead product candidates are Ivospemin (SBP-101), a proprietary polyamine analogue, which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; Flynpovi, a combination of eflornithine (CPP-1X) and sulindac which is in Phase III clinical trials; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase, currently under Phase I/II trial. It has a research agreement with the Johns Hopkins University School of Medicine for the development of ivospemin. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020.

Frequently asked questions

What percentage of Panbela Therapeutics is owned by insiders?
Currently 0.001% of Panbela Therapeutics shares are held by insiders. How many people work for Panbela Therapeutics?
Latest data suggests 7 work at Panbela Therapeutics. When does the fiscal year end for Panbela Therapeutics?
Panbela Therapeutics's fiscal year ends in December. Where is Panbela Therapeutics based?
Panbela Therapeutics's address is: 712 Vista Boulevard, Waconia, MN, United States, 55387 What is Panbela Therapeutics's ISIN number?
Panbela Therapeutics's international securities identification number is: US69833W1071